Invesco Ltd. grew its stake in TrueBlue, Inc. (NYSE:TBI - Free Report) by 2.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,080,030 shares of the business services provider's stock after buying an additional 47,089 shares during the period. Invesco Ltd. owned approximately 6.97% of TrueBlue worth $11,045,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in TBI. Nuveen Asset Management LLC lifted its position in shares of TrueBlue by 262.7% in the fourth quarter. Nuveen Asset Management LLC now owns 561,093 shares of the business services provider's stock worth $4,713,000 after buying an additional 406,405 shares during the last quarter. Royce & Associates LP lifted its position in shares of TrueBlue by 23.5% during the 1st quarter. Royce & Associates LP now owns 1,880,732 shares of the business services provider's stock worth $9,987,000 after purchasing an additional 357,539 shares during the last quarter. Peapod Lane Capital LLC acquired a new position in shares of TrueBlue during the 1st quarter worth about $1,385,000. GSA Capital Partners LLP lifted its position in shares of TrueBlue by 527.3% during the 1st quarter. GSA Capital Partners LLP now owns 287,625 shares of the business services provider's stock worth $1,527,000 after purchasing an additional 241,777 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of TrueBlue by 46.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 613,852 shares of the business services provider's stock worth $3,260,000 after purchasing an additional 194,155 shares during the last quarter. Institutional investors and hedge funds own 97.15% of the company's stock.
Analyst Ratings Changes
Separately, BMO Capital Markets boosted their price objective on TrueBlue from $7.00 to $8.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus price target of $8.00.
Read Our Latest Analysis on TBI
TrueBlue Trading Down 0.2%
Shares of TBI traded down $0.01 during trading hours on Thursday, reaching $6.06. The stock had a trading volume of 53,506 shares, compared to its average volume of 243,924. The firm has a 50-day moving average of $6.51 and a 200 day moving average of $5.89. The company has a market cap of $181.13 million, a P/E ratio of -5.23 and a beta of 1.55. The company has a quick ratio of 1.94, a current ratio of 1.94 and a debt-to-equity ratio of 0.18. TrueBlue, Inc. has a 52 week low of $3.45 and a 52 week high of $9.05.
TrueBlue (NYSE:TBI - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The business services provider reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.24. TrueBlue had a negative return on equity of 5.74% and a negative net margin of 2.21%.The company had revenue of $396.30 million during the quarter, compared to analysts' expectations of $400.52 million. TrueBlue has set its Q3 2025 guidance at EPS. On average, sell-side analysts expect that TrueBlue, Inc. will post 0.15 earnings per share for the current fiscal year.
About TrueBlue
(
Free Report)
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
Featured Stories

Before you consider TrueBlue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TrueBlue wasn't on the list.
While TrueBlue currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.